Company Overview of AMRI Rensselaer, Inc.
AMRI Rensselaer, Inc. operates as a contract current Good Manufacturing Practices manufacturing of bulk active pharmaceuticals and advanced intermediates for clinical trial supplies and commercial products in the United States. AMRI Rensselaer, Inc. was formerly known as Organichem Corporation and changed its name to AMRI Rensselaer, Inc. in May, 2007. The company was founded in 1999 and is based in Rensselaer, New York. AMRI Rensselaer, Inc. operates as a subsidiary of Albany Molecular Research Inc.
33 Riverside Avenue
Rensselaer, NY 12144-2906
Founded in 1999
Key Executives for AMRI Rensselaer, Inc.
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact AMRI Rensselaer, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.